vs
波士顿科学（MLSS）与Instil Bio, Inc.（TIL）财务数据对比。点击上方公司名可切换其他公司
Instil Bio, Inc.的季度营收约是波士顿科学的1.1倍（$2.2M vs $2.1M），波士顿科学净利率更高（-53.0% vs -365.3%，领先312.4%），波士顿科学同比增速更快（2.2% vs -19.2%）
波士顿科学公司是源自美国的跨国生物医疗企业，专业研发生产介入医疗领域医疗器械，产品覆盖介入放射学、介入心脏病学、外周介入治疗、神经调控、神经血管介入、电生理、心脏外科、血管外科、内镜、肿瘤学、泌尿与妇科等多个领域。
Instil Bio Inc.是一家临床阶段生物技术企业，专注于研发肿瘤浸润淋巴细胞（TIL）疗法，用于治疗难治性晚期实体瘤，面向对现有标准癌症治疗方案应答有限的患者群体，核心业务属于肿瘤免疫疗法领域。
MLSS vs TIL — 直观对比
营收规模更大
TIL
是对方的1.1倍
$2.1M
营收增速更快
MLSS
高出21.4%
-19.2%
净利率更高
MLSS
高出312.4%
-365.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.1M | $2.2M |
| 净利润 | $-1.1M | $-8.2M |
| 毛利率 | 73.0% | — |
| 营业利润率 | -52.5% | -426.3% |
| 净利率 | -53.0% | -365.3% |
| 营收同比 | 2.2% | -19.2% |
| 净利润同比 | 46.4% | 31.1% |
| 每股收益（稀释后） | — | $-1.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MLSSTIL
| Q4 25 | $2.1M | $2.2M | ||
| Q3 25 | $2.4M | $2.2M | ||
| Q2 25 | $2.3M | $2.2M | ||
| Q1 25 | $2.2M | $2.2M | ||
| Q4 24 | $2.0M | $2.8M | ||
| Q3 24 | $2.5M | $1.5M | ||
| Q2 24 | $1.9M | $0 | ||
| Q1 24 | $2.2M | $0 |
净利润MLSSTIL
| Q4 25 | $-1.1M | $-8.2M | ||
| Q3 25 | $-1.2M | $-13.6M | ||
| Q2 25 | $-1.5M | $-21.4M | ||
| Q1 25 | $-2.0M | $-28.2M | ||
| Q4 24 | $-2.0M | $-11.9M | ||
| Q3 24 | $-1.5M | $-23.0M | ||
| Q2 24 | $223.6K | $-14.9M | ||
| Q1 24 | $-1.4M | $-24.3M |
毛利率MLSSTIL
| Q4 25 | 73.0% | — | ||
| Q3 25 | 69.5% | — | ||
| Q2 25 | 69.6% | — | ||
| Q1 25 | 73.8% | — | ||
| Q4 24 | 75.0% | — | ||
| Q3 24 | 73.0% | — | ||
| Q2 24 | 76.1% | — | ||
| Q1 24 | 74.5% | — |
营业利润率MLSSTIL
| Q4 25 | -52.5% | -426.3% | ||
| Q3 25 | -48.1% | -670.0% | ||
| Q2 25 | -63.9% | -1045.5% | ||
| Q1 25 | -89.5% | -1363.2% | ||
| Q4 24 | -101.4% | -426.1% | ||
| Q3 24 | -58.4% | -1582.8% | ||
| Q2 24 | -96.0% | — | ||
| Q1 24 | -65.1% | — |
净利率MLSSTIL
| Q4 25 | -53.0% | -365.3% | ||
| Q3 25 | -48.9% | -606.0% | ||
| Q2 25 | -63.8% | -954.2% | ||
| Q1 25 | -89.3% | -1257.8% | ||
| Q4 24 | -101.1% | -428.8% | ||
| Q3 24 | -58.1% | -1541.9% | ||
| Q2 24 | 12.1% | — | ||
| Q1 24 | -64.1% | — |
每股收益（稀释后）MLSSTIL
| Q4 25 | — | $-1.13 | ||
| Q3 25 | $-0.01 | $-2.01 | ||
| Q2 25 | — | $-3.24 | ||
| Q1 25 | — | $-4.32 | ||
| Q4 24 | — | $-1.82 | ||
| Q3 24 | $-0.02 | $-3.54 | ||
| Q2 24 | — | $-2.29 | ||
| Q1 24 | — | $-3.74 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1M | $6.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.8M | $113.9M |
| 总资产 | $7.8M | $203.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MLSSTIL
| Q4 25 | $1.1M | $6.6M | ||
| Q3 25 | $1.3M | $5.8M | ||
| Q2 25 | $1.3M | $7.7M | ||
| Q1 25 | $2.2M | $15.4M | ||
| Q4 24 | $3.3M | $8.8M | ||
| Q3 24 | $4.8M | $6.7M | ||
| Q2 24 | $5.8M | $6.8M | ||
| Q1 24 | $5.0M | $5.5M |
股东权益MLSSTIL
| Q4 25 | $2.8M | $113.9M | ||
| Q3 25 | $2.5M | $120.4M | ||
| Q2 25 | $3.3M | $131.7M | ||
| Q1 25 | $4.5M | $144.9M | ||
| Q4 24 | $5.8M | $169.4M | ||
| Q3 24 | $7.2M | $176.3M | ||
| Q2 24 | $8.0M | $195.0M | ||
| Q1 24 | $7.5M | $205.8M |
总资产MLSSTIL
| Q4 25 | $7.8M | $203.5M | ||
| Q3 25 | $8.5M | $211.8M | ||
| Q2 25 | $8.1M | $231.0M | ||
| Q1 25 | $9.1M | $237.4M | ||
| Q4 24 | $9.8M | $263.6M | ||
| Q3 24 | $11.2M | $272.6M | ||
| Q2 24 | $12.0M | $294.3M | ||
| Q1 24 | $11.4M | $306.3M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-226.1K | $-7.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MLSSTIL
| Q4 25 | $-226.1K | $-7.1M | ||
| Q3 25 | $81.8K | $-10.6M | ||
| Q2 25 | $-1.8M | $-14.8M | ||
| Q1 25 | $-1.0M | $-4.2M | ||
| Q4 24 | $-1.5M | $-10.6M | ||
| Q3 24 | $-973.9K | $-20.1M | ||
| Q2 24 | $783.7K | $-10.6M | ||
| Q1 24 | $-1.2M | $-14.4M |
资本支出强度MLSSTIL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率MLSSTIL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.50× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
